This study looked at the use of citicoline and vitamin B12 eye drops (OMK2) to prevent diabetic retinopathy (DR; eye disease) in patients with type 1 diabetes (T1D). It found that using these drops for 36 months improved eye function tests. 

This study looked at remote screening for diabetic retinopathy (DR; eye disease) in a Japanese population. This study showed that remote screening for DR is an effective way of identifying patients who need ophthalmic intervention.

This study analyzed the effectiveness of pioglitazone (Actos) in patients with prediabetes or type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD). The authors concluded that pioglitazone can significantly improve liver function in these patients.

This study aimed to explore the effects of melatonin in addition to pregabalin (Lyrica) for the management of painful diabetic neuropathy (PDN). The authors concluded that melatonin added to pregabalin may help in reducing pain related to PDN in patients with type 2 diabetes (T2D).

This study looked at how the Diabeloop system managed exercise for patients with type 1 diabetes (T1D). It found that people using this system did not have more hypoglycemia (dangerously low blood sugar) on days with exercise.

This study looked at 8 glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes (T2D). They found that all 8 were more effective than placebo and there were no significant differences in safety.

This review looked at whether exercise can improve heart rate variability (HRV) for patients with type 2 diabetes (T2D). It found that exercise improved HRV, which indicates better nerve health of the heart.